$PLTK
Playtika Holding Corp. Stock $pltk

$pltk Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000182801623000023 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$642.8M	$656.2M
YoY Change	-2.55%	-3.06%
Cost Of Revenue	$188.0M	$185.7M
YoY Change	1.02%	-0.64%
Gross Profit	$454.8M	$470.5M
YoY Change	-3.95%	-3.98%
Gross Profit Margin	70.75%	71.7%
Selling, General & Admin	$215.3M	$215.7M
YoY Change	-16.23%	-16.04%
% of Gross Profit	47.34%	45.84%
Research & Development	$100.3M	$102.4M
YoY Change	-19.89%	-9.14%
% of Gross Profit	22.05%	21.76%
Depreciation & Amortization	$48.20M	$11.60M
YoY Change	13.15%	7.41%
% of Gross Profit	10.6%	2.47%
Operating Expenses	$315.6M	$318.1M
YoY Change	-17.43%	-13.93%
Operating Profit	$139.2M	$152.4M
YoY Change	52.46%	26.58%
Interest Expense	$35.80M	$38.00M
YoY Change	38.22%	60.34%
% of Operating Profit	25.72%	24.93%
Other Income/Expense, Net	$0.00	-$200.0K
YoY Change	-100.0%
Pretax Income	$116.1M	$123.8M
YoY Change	68.51%	33.26%
Income Tax	$40.40M	$39.70M
% Of Pretax Income	34.8%	32.07%
Net Earnings	$75.70M	$84.10M
YoY Change	107.97%	1.08%
Net Earnings / Revenue	11.78%	12.82%
Basic Earnings Per Share	$0.21	$0.23
Diluted Earnings Per Share	$0.21	$0.23
COMMON SHARES
Basic Shares Outstanding	365.7M shares	365.3M shares
Diluted Shares Outstanding	366.4M shares	365.1M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$955.1M	$767.2M
YoY Change	-23.04%	-30.75%
Cash & Equivalents	$955.1M	$767.2M
Short-Term Investments
Other Short-Term Assets	$110.1M	$104.9M
YoY Change	-6.06%	5.75%
Inventory
Prepaid Expenses
Receivables	$159.8M	$176.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.225B	$1.049B
YoY Change	-17.61%	-22.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$112.9M	$119.2M
YoY Change	1.8%	12.88%
Goodwill	$813.2M	$813.3M
YoY Change	0.42%	-1.93%
Intangibles	$313.6M	$337.9M
YoY Change	-20.59%	-19.41%
Long-Term Investments	$54.10M	$52.80M
YoY Change	137.28%	196.63%
Other Assets	$157.4M	$150.6M
YoY Change	428.19%	390.55%
Total Long-Term Assets	$1.620B	$1.646B
YoY Change	6.63%	6.72%
TOTAL ASSETS
Total Short-Term Assets	$1.225B	$1.049B
Total Long-Term Assets	$1.620B	$1.646B
Total Assets	$2.845B	$2.694B
YoY Change	-5.36%	-6.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.30M	$38.80M
YoY Change	-16.23%	-7.4%
Accrued Expenses	$93.20M	$95.00M
YoY Change	-39.99%	-32.53%
Deferred Revenue	$44.60M	$39.60M
YoY Change	45.75%	27.74%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.70M	$12.10M
YoY Change	-5.65%	-0.82%
Total Short-Term Liabilities	$410.6M	$357.4M
YoY Change	-33.39%	-32.76%
LONG-TERM LIABILITIES
Long-Term Debt	$2.406B	$2.409B
YoY Change	-0.48%	-0.49%
Other Long-Term Liabilities	$245.4M	$255.0M
YoY Change	140.12%	110.74%
Total Long-Term Liabilities	$2.651B	$2.664B
YoY Change	9.68%	10.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$410.6M	$357.4M
Total Long-Term Liabilities	$2.651B	$2.664B
Total Liabilities	$3.190B	$3.155B
YoY Change	-0.01%	0.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$982.8M	-$1.059B
YoY Change	-24.3%	-20.69%
Common Stock	$4.100M	$4.100M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$344.9M	-$460.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.845B	$2.694B
YoY Change	-5.36%	-6.74%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$75.70M	$84.10M
YoY Change	107.97%	1.08%
Depreciation, Depletion And Amortization	$48.20M	$11.60M
YoY Change	13.15%	7.41%
Cash From Operating Activities	$207.0M	$20.50M
YoY Change	13.11%	-64.72%
INVESTING ACTIVITIES
Capital Expenditures	$16.70M	$5.000M
YoY Change	-159.01%	-61.54%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$900.0K	$200.0K
YoY Change	-100.64%
Cash From Investing Activities	-$17.60M	-$15.40M
YoY Change	-115.58%	-91.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.300M	-$6.100M
YoY Change	-1.85%	-1.61%
NET CHANGE
Cash From Operating Activities	207.0M	$20.50M
Cash From Investing Activities	-17.60M	-$15.40M
Cash From Financing Activities	-5.300M	-$6.100M
Net Change In Cash	184.1M	-$1.400M
YoY Change	-36.65%	-98.93%
FREE CASH FLOW
Cash From Operating Activities	$207.0M	$20.50M
Capital Expenditures	$16.70M	$5.000M
Free Cash Flow	$190.3M	$15.50M
YoY Change	-9.94%	-65.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001828016
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q1	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q1	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39896
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	PLAYTIKA HOLDING CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-3634591
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	HaChoshlim St 8
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Herzliya Pituach
CY2023Q1	dei	Entity Address Country EntityAddressCountry	IL
CY2023Q1	dei	City Area Code CityAreaCode	972-73
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	316-3251
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	PLTK
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	365733480	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	767200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	768700000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	1800000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	1700000	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	176500000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	141100000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	103100000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	113400000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1048600000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1024900000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	125700000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103300000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	104200000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	337900000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	354000000.0	usd
CY2023Q1	us-gaap	Goodwill Goodwill	813300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	811200000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	68600000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	68300000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	52800000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	52600000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	150600000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	156700000	usd
CY2023Q1	us-gaap	Assets Assets	2694300000	usd
CY2022Q4	us-gaap	Assets Assets	2697600000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12100000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12400000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	38800000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	50700000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13500000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	290900000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	385200000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	357400000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	461800000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	2408500000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2411200000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	255000000.0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	252100000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93000000.0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	94500000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	41100000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	46600000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3155000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3266200000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1600000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1600000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	365600000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	365600000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	363600000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	363600000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	4100000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4100000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	51800000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	51800000	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	603500000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	603500000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1184300000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1155800000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12900000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17600000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1058500000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1142600000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-460700000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-568600000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2694300000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2697600000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	656200000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	676900000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	185700000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	186900000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102400000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	112700000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	143700000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	179700000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	72000000.0	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	77200000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	503800000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	556500000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	152400000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	120400000	usd
CY2023Q1	playtika	Interest Expense And Other Net InterestExpenseAndOtherNet	28600000	usd
CY2022Q1	playtika	Interest Expense And Other Net InterestExpenseAndOtherNet	27500000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	123800000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	92900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39700000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	84100000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	83200000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-7800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	18700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4700000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	15400000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	79400000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	98600000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	364600000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	412000000.0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365100000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	412500000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-568600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	84100000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29800000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4700000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-460700000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-377700000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	83200000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	40500000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1400000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	15400000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-240000000.0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	84100000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	83200000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	11600000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	10800000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27500000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28700000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29200000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39800000	usd
CY2023Q1	playtika	Amortization And Write Off Of Loan Discount AmortizationAndWriteOffOfLoanDiscount	1700000	usd
CY2022Q1	playtika	Amortization And Write Off Of Loan Discount AmortizationAndWriteOffOfLoanDiscount	2100000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-22100000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3500000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	4100000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-900000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2100000	usd
CY2023Q1	playtika	Non Cash Lease Expense Income NonCashLeaseExpenseIncome	-1400000	usd
CY2022Q1	playtika	Non Cash Lease Expense Income NonCashLeaseExpenseIncome	1100000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35000000.0	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16500000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	19800000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11900000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3500000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-102000000.0	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-62000000.0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20500000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58100000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000000.0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13000000.0	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	8100000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	13500000	usd
CY2023Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	2100000	usd
CY2022Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	2400000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	0	usd
CY2022Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	122100000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	29300000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	200000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15400000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-180300000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	4800000	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	4800000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1300000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6100000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6200000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-400000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2800000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1400000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-131200000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	770400000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1019000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	769000000.0	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	887800000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	39900000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	24800000	usd
CY2023Q1	playtika	Cash Paid For Interest CashPaidForInterest	41600000	usd
CY2022Q1	playtika	Cash Paid For Interest CashPaidForInterest	27700000	usd
CY2023Q1	playtika	Cash Received For Interest CashReceivedForInterest	6900000	usd
CY2022Q1	playtika	Cash Received For Interest CashReceivedForInterest	100000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3700000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14100000	usd
CY2023Q1	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	0	usd
CY2022Q1	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	30000000.0	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	600000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	700000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	170300000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of credit risk and significant customers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, accounts receivable and derivative contracts. The Company’s investment policy imposes certain maturity limits on the Company’s portfolio and restricts the permitted investments to the purchase of bank deposits and highly rated fixed income securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apple, Facebook and Google are significant distribution, marketing, promotion and payment platforms for the Company's games. A significant portion of the Company’s revenues has been generated from players who accessed the Company's games through these platforms. Therefore, the Company's accounts receivable are derived mainly from sales through these </span></div>three platforms. Accounts receivable are recorded at their transaction amounts and do not bear interest. The Company performs ongoing credit evaluations of its customers.
CY2023Q1	playtika	Number Of Distribution Marketing Promotion And Payment Platforms NumberOfDistributionMarketingPromotionAndPaymentPlatforms	3	platform
CY2023Q1	playtika	Derivatives Effectiveness Number Of Observations DerivativesEffectivenessNumberOfObservations	30	observation
CY2023Q1	playtika	Media Buy Expenses Current MediaBuyExpensesCurrent	47400000	usd
CY2022Q4	playtika	Media Buy Expenses Current MediaBuyExpensesCurrent	41300000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	95000000.0	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	110100000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	93100000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	39600000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	38600000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	15800000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	24900000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	290900000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	385200000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2420600000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2462000000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2423600000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12100000	usd
CY2023Q1	playtika	Debt Instrument Face Amount Current Portion DebtInstrumentFaceAmountCurrentPortion	19000000.0	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12400000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2408500000	usd
CY2023Q1	playtika	Debt Instrument Face Amount Net Current Portion DebtInstrumentFaceAmountNetCurrentPortion	2443000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2411200000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	41400000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	43200000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	17404915	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3400000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.08
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.21
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1100000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	20.11
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2300000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.59
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	400000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1200000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.24
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100000	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	656200000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	676900000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	9.72
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	29800000	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	40500000	usd
CY2023Q1	playtika	Share Based Compensation Expense Net Of Amounts Capitalized ShareBasedCompensationExpenseNetOfAmountsCapitalized	29200000	usd
CY2022Q1	playtika	Share Based Compensation Expense Net Of Amounts Capitalized ShareBasedCompensationExpenseNetOfAmountsCapitalized	39800000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	600000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	700000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2462000000	usd
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2346700000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2466800000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2262500000	usd
CY2023Q1	playtika	Number Of Demand Received NumberOfDemandReceived	7	demand
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	656200000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	676900000	usd
CY2023Q1	playtika	Contract Receivable Collection Period ContractReceivableCollectionPeriod	P45D
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	176500000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	141100000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	10900000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	10800000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	39600000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	38600000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	21800000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q1	playtika	Long Lived Assets And Deferred Tax Assets Net LongLivedAssetsAndDeferredTaxAssetsNet	222500000	usd
CY2022Q4	playtika	Long Lived Assets And Deferred Tax Assets Net LongLivedAssetsAndDeferredTaxAssetsNet	229900000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	38000000.0	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	23700000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	7800000	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	800000	usd
CY2023Q1	playtika	Foreign Currency Translation Differences ForeignCurrencyTranslationDifferences	1800000	usd
CY2022Q1	playtika	Foreign Currency Translation Differences ForeignCurrencyTranslationDifferences	-3500000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-200000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1100000	usd
CY2023Q1	playtika	Interest Expense And Other Net InterestExpenseAndOtherNet	28600000	usd
CY2022Q1	playtika	Interest Expense And Other Net InterestExpenseAndOtherNet	27500000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	123800000	usd
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	92900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39700000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9700000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.321
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.104
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-2900000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-1800000	usd
CY2022Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	14700000	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	84100000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	83200000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	364600000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	412000000.0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	500000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	500000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365100000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	412500000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16100000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27100000	shares

Files In Submission

Name	View Source	Status
0001828016-23-000023-index-headers.html	Edgar Link	pending
0001828016-23-000023-index.html	Edgar Link	pending
0001828016-23-000023.txt	Edgar Link	pending
0001828016-23-000023-xbrl.zip	Edgar Link	pending
a2023q1-ex311xceo302cert.htm	Edgar Link	pending
a2023q1-ex312xcfo302cert.htm	Edgar Link	pending
a2023q1-ex321xceo906cert.htm	Edgar Link	pending
a2023q1-ex322xcfo906cert.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
playtika-20230331.htm	Edgar Link	pending
playtika-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
playtika-20230331_def.xml	Edgar Link	unprocessable
playtika-20230331_cal.xml	Edgar Link	unprocessable
playtikaltdemploymentagree.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
playtika-20230331_lab.xml	Edgar Link	unprocessable
playtika-20230331_htm.xml	Edgar Link	completed
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
playtika-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLTK
Playtika Holding Corp. Stock $pltk

2023 Q2 Form 10-Q Financial Statement

#000182801623000023 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLTK Playtika Holding Corp. Stock $pltk

2023 Q2 Form 10-Q Financial Statement

#000182801623000023 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLTK
Playtika Holding Corp. Stock $pltk